BE710483A - - Google Patents

Info

Publication number
BE710483A
BE710483A BE710483DA BE710483A BE 710483 A BE710483 A BE 710483A BE 710483D A BE710483D A BE 710483DA BE 710483 A BE710483 A BE 710483A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE710483A publication Critical patent/BE710483A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE710483D 1967-11-24 1968-02-07 BE710483A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR129489A FR6928M (cg-RX-API-DMAC7.html) 1967-11-24 1967-11-24

Publications (1)

Publication Number Publication Date
BE710483A true BE710483A (cg-RX-API-DMAC7.html) 1968-06-17

Family

ID=8642199

Family Applications (1)

Application Number Title Priority Date Filing Date
BE710483D BE710483A (cg-RX-API-DMAC7.html) 1967-11-24 1968-02-07

Country Status (3)

Country Link
BE (1) BE710483A (cg-RX-API-DMAC7.html)
FR (1) FR6928M (cg-RX-API-DMAC7.html)
GB (1) GB1175808A (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048090B1 (es) * 1992-01-31 1994-10-01 Rovi Lab Farmaceut Sa Procedimiento para la obtencion de nuevos antitromboticos derivados de la cumarina.
WO1996031206A2 (en) * 1995-04-07 1996-10-10 Warner-Lambert Company Flavones and coumarins as agents for the treatment of atherosclerosis
EP2332527A3 (en) 2004-10-20 2011-11-16 Resverlogix Corp. Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
AU2006275514B2 (en) * 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
DK2118074T3 (en) 2007-02-01 2014-03-10 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular diseases
EP2346837B8 (en) 2008-06-26 2015-04-15 Resverlogix Corporation Methods of preparing quinazolinone derivatives
AU2010204106B2 (en) 2009-01-08 2014-05-08 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
CN102427813A (zh) 2009-03-18 2012-04-25 雷斯韦洛吉克斯公司 新的抗炎剂
EP2421533B1 (en) 2009-04-22 2018-10-17 Resverlogix Corp. Novel anti-inflammatory agents
EP2773354B1 (en) 2011-11-01 2019-06-12 Resverlogix Corp. Oral immediate release formulations for substituted quinazolinones
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
CA2895905A1 (en) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Novel heterocyclic compounds as bromodomain inhibitors
EP3268007B1 (en) 2015-03-13 2022-11-09 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Also Published As

Publication number Publication date
GB1175808A (en) 1969-12-23
FR6928M (cg-RX-API-DMAC7.html) 1969-05-05

Similar Documents

Publication Publication Date Title
AT298283B (cg-RX-API-DMAC7.html)
AU416737B2 (cg-RX-API-DMAC7.html)
AU342066A (cg-RX-API-DMAC7.html)
AU3189468A (cg-RX-API-DMAC7.html)
AU2256867A (cg-RX-API-DMAC7.html)
AU2116667A (cg-RX-API-DMAC7.html)
AU1273466A (cg-RX-API-DMAC7.html)
AU3151267A (cg-RX-API-DMAC7.html)
BE708996A (cg-RX-API-DMAC7.html)
BE609869A (cg-RX-API-DMAC7.html)
BE711467A (cg-RX-API-DMAC7.html)
AU1614766A (cg-RX-API-DMAC7.html)
BE711013A (cg-RX-API-DMAC7.html)
BE710563A (cg-RX-API-DMAC7.html)
BE710334A (cg-RX-API-DMAC7.html)
BE710272A (cg-RX-API-DMAC7.html)
BE710157A (cg-RX-API-DMAC7.html)
BE709976A (cg-RX-API-DMAC7.html)
AU1677166A (cg-RX-API-DMAC7.html)
BE709392A (cg-RX-API-DMAC7.html)
AU1868267A (cg-RX-API-DMAC7.html)
BE709052A (cg-RX-API-DMAC7.html)
BE711550A (cg-RX-API-DMAC7.html)
AU459699A (cg-RX-API-DMAC7.html)
BE609934A (cg-RX-API-DMAC7.html)